AAAAAA
Results: 51-75/363
Authors:
PESKIND ER
LEVERENZ J
FARLOW MR
ITO RK
PROVOW SA
SIEGEL RS
CLEVELAND M
MORGAN CH
PANDIAN MR
CORBIN S
NOCHLIN D
SCHELLENBERG GD
RASKIND MA
WAGNER SL
Citation: Er. Peskind et al., CLINICOPATHOLOGICAL CORRELATIONS OF SOLUBLE AMYLOID BETA-PROTEIN PRECURSOR IN CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMER-DISEASE AND CONTROLS, Alzheimer disease and associated disorders, 11(4), 1997, pp. 201-206
Authors:
BANCHER C
PAULUS W
PAUKNER K
JELLINGER K
Citation: C. Bancher et al., NEUROPATHOLOGIC DIAGNOSIS OF ALZHEIMER-DISEASE - CONSENSUS BETWEEN PRACTICING NEUROPATHOLOGISTS, Alzheimer disease and associated disorders, 11(4), 1997, pp. 207-219
Authors:
IBARRETA D
PARRILLA R
AYUSO MS
Citation: D. Ibarreta et al., ALTERED CA2-ONSET ALZHEIMER-DISEASE( HOMEOSTASIS IN LYMPHOBLASTS FROMPATIENTS WITH LATE), Alzheimer disease and associated disorders, 11(4), 1997, pp. 220-227
Authors:
VANHAITSMA K
LAWTON MP
KLEBAN MH
KLAPPER J
CORN J
Citation: K. Vanhaitsma et al., METHODOLOGICAL ASPECTS OF THE STUDY OF STREAMS OF BEHAVIOR IN ELDERS WITH DEMENTING ILLNESS, Alzheimer disease and associated disorders, 11(4), 1997, pp. 228-238
Authors:
CUMMINGS JL
Citation: Jl. Cummings, CHANGES IN NEUROPSYCHIATRIC SYMPTOMS AS OUTCOME MEASURES IN CLINICAL-TRIALS WITH CHOLINERGIC THERAPIES FOR ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 1-9
Authors:
CUMMINGS JL
Citation: Jl. Cummings, BEHAVIOR AS AN EFFICACY OUTCOME, Alzheimer disease and associated disorders, 11, 1997, pp. 5-6
Authors:
FERRIS SH
MACKELL JA
Citation: Sh. Ferris et Ja. Mackell, BEHAVIORAL OUTCOMES IN CLINICAL-TRIALS FOR ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 10-15
Authors:
BODICK NC
OFFEN WW
SHANNON HE
SATTERWHITE J
LUCAS R
VANLIER R
PAUL SM
Citation: Nc. Bodick et al., THE SELECTIVE MUSCARINIC AGONIST XANOMELINE IMPROVES BOTH THE COGNITIVE DEFICITS AND BEHAVIORAL SYMPTOMS OF ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11, 1997, pp. 16-22
Authors:
SUNDERLAND T
MOLCHAN SE
LITTLE JT
BAHRO M
PUTNAM KT
WEINGARTNER H
Citation: T. Sunderland et al., PHARMACOLOGICAL CHALLENGES IN ALZHEIMER-DISEASE AND NORMAL CONTROLS -COGNITIVE MODELING IN HUMANS, Alzheimer disease and associated disorders, 11, 1997, pp. 23-26
Authors:
CACABELOS R
RODRIGUEZ B
CARRERA C
BEYER K
LAO JI
SELLERS MA
Citation: R. Cacabelos et al., BEHAVIORAL-CHANGES ASSOCIATED WITH DIFFERENT APOLIPOPROTEIN-E GENOTYPES IN DEMENTIA, Alzheimer disease and associated disorders, 11, 1997, pp. 27-34
Authors:
TERI L
Citation: L. Teri, BEHAVIOR AND CAREGIVER BURDEN - BEHAVIORAL-PROBLEMS IN PATIENTS WITH ALZHEIMER-DISEASE AND ITS ASSOCIATION WITH CAREGIVER DISTRESS, Alzheimer disease and associated disorders, 11, 1997, pp. 35-38
Authors:
LEHFELD H
REISBERG B
FINKEL S
KANOWSKI S
WIED V
PITTAS J
TSOLAKI M
ROBERT PH
HULLA F
HEININGER K
ERZIGKEIT H
Citation: H. Lehfeld et al., INFORMANT-RATED ACTIVITIES-OF-DAILY-LIVING (ADL) ASSESSMENTS - RESULTS OF A STUDY OF 141 ITEMS IN THE USA, GERMANY, RUSSIA, AND GREECE FROMTHE INTERNATIONAL ADL SCALE DEVELOPMENT PROJECT, Alzheimer disease and associated disorders, 11, 1997, pp. 39-44
Authors:
NEUNDORFER MM
Citation: Mm. Neundorfer, AWARENESS OF VARIABILITY IN AWARENESS, Alzheimer disease and associated disorders, 11(3), 1997, pp. 121-122
Authors:
HARDING JJ
Citation: Jj. Harding, ALZHEIMER-DISEASE AND CATARACT - COMMON THREADS, Alzheimer disease and associated disorders, 11(3), 1997, pp. 123-123
Authors:
WAGNER MT
SPANGENBERG KB
BACHMAN DL
OCONNELL P
Citation: Mt. Wagner et al., UNAWARENESS OF COGNITIVE DEFICIT IN ALZHEIMER-DISEASE AND RELATED DEMENTIAS, Alzheimer disease and associated disorders, 11(3), 1997, pp. 125-131
Authors:
NAKAMURA T
MEGURO K
YAMAZAKI H
OKUZUMI H
TANAKA A
HORIKAWA A
YAMAGUCHI K
KATSUYAMA N
NAKANO M
ARAI H
SASAKI H
Citation: T. Nakamura et al., POSTURAL AND GAIT DISTURBANCE CORRELATED WITH DECREASED FRONTAL CEREBRAL BLOOD-FLOW IN ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11(3), 1997, pp. 132-139
Authors:
SIMONE PM
BAYLIS GC
Citation: Pm. Simone et Gc. Baylis, THE ROLE OF ATTENTION IN A SPATIAL MEMORY TASK IN ALZHEIMER-DISEASE PATIENTS, Alzheimer disease and associated disorders, 11(3), 1997, pp. 140-152
Authors:
GREEN JB
BURBA A
FREED DM
ELDER WW
XU WC
Citation: Jb. Green et al., THE P1 COMPONENT OF THE MIDDLE LATENCY AUDITORY POTENTIAL MAY DIFFERENTIATE A BRAIN-STEM SUBGROUP OF ALZHEIMER-DISEASE, Alzheimer disease and associated disorders, 11(3), 1997, pp. 153-157
Authors:
JORM AF
Citation: Af. Jorm, METHODS OF SCREENING FOR DEMENTIA - A METAANALYSIS OF STUDIES COMPARING AN INFORMANT QUESTIONNAIRE WITH A BRIEF COGNITIVE TEST, Alzheimer disease and associated disorders, 11(3), 1997, pp. 158-162
Authors:
MARTIN ES
MARTIN SE
EDELSOHN L
BORGAONKAR DS
Citation: Es. Martin et al., STUDIES IN A LARGE FAMILY WITH LATE-ONSET ALZHEIMER-DISEASE (LOAD), Alzheimer disease and associated disorders, 11(3), 1997, pp. 163-170
Authors:
SCHERDER EJA
BOUMA A
Citation: Eja. Scherder et A. Bouma, IS DECREASED USE OF ANALGESICS IN ALZHEIMER-DISEASE DUE TO A CHANGE IN THE AFFECTIVE COMPONENT OF PAIN, Alzheimer disease and associated disorders, 11(3), 1997, pp. 171-174
Authors:
COLENDA CC
COHEN W
MCCALL WV
ROSENQUIST PB
Citation: Cc. Colenda et al., PHOTOTHERAPY FOR PATIENTS WITH ALZHEIMER-DISEASE WITH DISTURBED SLEEPPATTERNS - RESULTS OF A COMMUNITY-BASED PILOT-STUDY, Alzheimer disease and associated disorders, 11(3), 1997, pp. 175-178
Authors:
WHITEHOUSE PJ
Citation: Pj. Whitehouse, REPORT OF THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES - INTRODUCTION, Alzheimer disease and associated disorders, 11, 1997, pp. 1-1
Authors:
WHITEHOUSE PJ
Citation: Pj. Whitehouse, THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES - PAST, PRESENT, AND FUTURE, Alzheimer disease and associated disorders, 11, 1997, pp. 2-5
Authors:
GAUTHIER S
BODICK N
ERZIGKEIT E
FELDMAN H
GELDMACHER DS
HUFF J
MOHS R
ORGOGOZO JM
ROGERS S
Citation: S. Gauthier et al., ACTIVITIES OF DAILY LIVING AS AN OUTCOME MEASURE IN CLINICAL-TRIALS OF DEMENTIA DRUGS - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUPON HARMONIZATION OF DEMENTIA DRUG GUIDELINES, Alzheimer disease and associated disorders, 11, 1997, pp. 6-7